Public health ethics and genetics in public health have in the last decade emerged as fields in their own right. This article describes the ethics component of an “Issues in Public Health Genetics” course uniting the fields of genetics, ethics, and public health. As the third member of the University of Michigan Interdepartmental Concentration in Genetics, the course emphasizes the translation of ethical-social issues into substantive policies. A central tension repeated throughout the course exists between respect for individuals’ libertarian interests and the welfare of the entire population. Students become familiar with the process of resolving conflicting values through interactive exercises addressing the health needs of diverse communities. Key lessons in course design are described.
Get full access to this article
View all access options for this article.
References
1.
1. Centers for Disease Control and Prevention: Human Genome Epidemiology Network (HuGE Net). World Wide Web URL: http://www.cdc.gov/genetics/default.htm, 2001.
2.
3.
4.
5.
5. Patton CV, Sawicki DS: Basic Methods of Policy Analysis and Planning (2nd ed.). Englewood Cliffs, NJ, Prentice Hall, 1993.
6.
6. Reilly PR, Page DC: We’re off to see the genome. Nat Genet20(1):15-17, 1998.
7.
7. Nelkin D: Genetic screening: What it means for health and ethics in the future. Curr Issues Public Health2(2):47-50, 1996.
8.
8. Murray TH: Ethical issues in human genome research. FASEB J5(1):55-60, 1991.
9.
9. O’Leary LA, Collins DL: Using the Internet to disseminate genetics information for public health, in Khoury MJ, Burke W, Thomson EJ (eds.): Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. New York, Oxford University Press, 2000, pp. 603-615.
10.
10. KitcherP: The Lives to Come: The Genetic Revolution and Human Possibilities. New York, Simon & Schuster, 1996.
11.
11. AlperJS, Beckwith J: Genetic fatalism and social policy: The implications of behaviorgenetics research. Yale J Biol Med66(6):511-524, 1994.
12.
12. Wikler DI: Persuasion and coercion for health: Ethical issues in government efforts to change life-styles. Milbank Memorial Fund Quarterly56(3):303-338, 1978.
13.
13. Guttman N: Ethical dilemmas in health campaigns. Health Commun9:155-190, 1997.
14.
14. Paul DB: Eugenic anxieties, social realities, and political choices. Soc Res59(3):663-683, 1992.
15.
15. Duster T: Backdoor to Eugenics. New York, Routledge, 1990.
16.
16. Kroner HP: From eugenics to genetic screening: Historical problems of human genetic applications, in Chadwick R, Shickle D, ten Have HT, Wiesing U (eds.): The Ethics of Genetic Screening. Dordrecht, The Netherlands, and Boston, Kluwer, 1999, pp. 131-145.
17.
17. Wikler DI: Can we learn from eugenics?J Med Ethics25(2):183-194, 1999.
18.
18. Pernick MS: Eugenics and public health in American history. Am J Public Health87(11):1767-1772, 1997.
19.
19. Macrina FL: Scientific Integrity: An Introductory Text with Cases (2nd ed.). Washington, DC, ASM, 2000.
20.
20. Holtzman NA, Andrews LB: Ethical and legal issues in genetic epidemiology. Epidemiol Rev19(1):163-174, 1997.
21.
21. Coughlin SS, Soskolne CL, Goodman KW: Case Studies in Public Health Ethics. Washington, DC, American Public Health Association, 1997.
22.
22. PenslarEL (ed.): Research Ethics: Cases and Materials. Bloomington, Indiana University Press, 1995.
23.
23. Marshall E: Gene therapy on trial. Science288(5468):951-957, 2000.
24.
24. Kolehmainen S: The dangerous promise of gene therapy. GeneWatch13(1):1-1, 6-9, 2000.
25.
25. Dickens BM: Legal and ethical challenges in gene therapy. Transfusion Science17(1):191-196, 1996.
26.
26. Juengst ET: “Prevention” and the goals of genetic medicine. Hum Gene Ther6(12):1595-1605, 1995.
27.
27. Khoury MJ: Public Health Policy Forum: From genes to public health: The applications of genetic technology in disease prevention. Am J Public Health86(12):1717-1722, 1996.
28.
28. Hoedemaekers R, ten Have HT, Chadwick R: Genetic screening: A comparative analysis of three recent reports. J Med Ethics23(3):135-141, 1997.
29.
29. Baumiller RC, Comley S, Cunningham G, et al: Code of ethical principles for genetics professionals (and explication). Am J Med Genet65(3):177-183, 1996.
30.
31.
31. American Public Health Association: Policy Statement#OPOC8732PP: Genetics and public health. Am J Public Health78(2):209-211, 1988.
32.
32. Shickle D: The Wilson and Jungner principles of screening and genetic testing, in Chadwick R, Shickle D, ten Have HT, Wieing U (eds.): The Ethics of Genetic Screening. Dordrecht, the Netherlands, and Boston: Kluwer, 1999, pp. 1-34.
33.
33. Natowicz MR, Alper JS: Genetic screening: Triumphs, problems, and controversies. J Public Health Policy12(4):475-491, 1991.
34.
34. Frankenburg WK: Principles of screening, in Frankenburg WK, Camp BW (eds.): Pediatric Screening Tests. Springfield, IL, Charles C Thomas, 1975, pp. 9-37.
35.
35. Alper JS, Geller LN, Barash CI, et al: Genetic discrimination and screening for hemochromatosis. J Public Health Policy15(3):345-358, 1994.
36.
36. Atwood K, Colditz GA, Kawachi I: From public health science to prevention policy: Placing science in its social and political contexts. Am J Public Health87(10):1603-1606, 1997.
37.
37. Thomas SB, Quin SC: Tuskegee: A red flag for bioethics. 128th American Public Health Association Annual Meeting & Exposition Abstracts5117.0: 506-506, 2000 (and accompanying session).
38.
38. Thomas SB, Curran JW: Tuskegee: From science to conspiracy to metaphor. Am J Med Sci317(1):1-8, 1999.
39.
39. Coughlin SS, Etheredge GD: Remember Tuskegee: Public health student knowledge of the ethical significance of the Tuskegee Syphilis Study. Am J Prev Med12(4):242-246, 1996.
40.
40. Panel session: Informing genetics policy: The future of public participation, in Modell SM, Hartman TC (eds.): Genome Horizons: Public Deliberations and Policy Pathways—Conference Proceedings. Ann Arbor, Michigan, Genome Technology & Reproduction: Values & Public Policy Project, 1998.
41.
41. Grady C: Science in the service of healing. Hastings Cent Rep28(6):34-38, 1998.
42.
42. Nickens H: The genome project and health services for minority populations, in Murray TH, Rothstein MA, Murray RF, Jr (eds.): The Human Genome Project and the Future of Health Care. Bloomington, Indiana University Press, 1996, pp. 58-78.
43.
43. King PA: The past as prologue: Race, class, and gene discrimination, in Annas GJ, Elias S (eds.): Gene Mapping: Using Law and Ethics as Guides. New York, Oxford University Press, 1992, pp. 94-111.
44.
44. Jackson F: African-American responses to the Human Genome Project. Public Understanding of Science8(3):181-191, 1999.
45.
45. Dukapoo FC: Commentary on “Scientific limitations and ethical ramifications of a non-representative Human Genome Project: African American responses.” An American Indian perspective. Sci Eng Ethics4(2):171-180, 1998.
46.
46. Weiss JO, Allen L, Marche-Escola S, et al: Consumer perspectives on genetic testing, research and services for ethnoculturally diverse populations. Community Genetics1(3):118-123, 1998.
47.
47. Dicke AA: Genetic risk and voluntary insurance. Contingencies8(5):52-56, 1996.
48.
48. Kass NE: Insurance for the insurers: The use of genetic tests. Hastings Cent Rep22(6):6-11, 1992.
49.
49. Pokorski RJ: A test for the insurance industry. Nature391(6670):835-836, 1998.
50.
50. SuterSM, Goldman EB: Policy Approaches/Recommendations. Ann Arbor, MI, Genome Technology & Reproduction: Values & Public Policy Project, 1998.
51.
52.
52. American Society of Human Genetics: ASHG Report: Statement on informed consent for genetic research. Am J Hum Genet59(2):471-474, 1996.
53.
53. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, et al: Consensus statement: Informed consent for genetic research on stored tissue samples. JAMA274(22):1786-1792, 1995.
54.
54. Annas GJ, Glantz LH, Roche PA: The Genetic Privacy Act and Commentary. World Wide Web URL: http://www.ornl.gov/TechResources/Human_Genome/resource/privacy/privacy1.html, 1995.
55.
55. Robertson JA: Privacy issues in second stage genomics. Jurimetrics40:59-76, 1999.
56.
56. Burris S, Gostin LO, Tress D: Public health surveillance of genetic information: Ethical and legal responses to social risk, in Khoury MJ, Burke W, Thomson EJ (eds.): Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. New York, Oxford University Press, 2000, pp. 527-546.
57.
57. Murray TH: Genetic exceptionalism and “future diaries”: Is genetic information different from othermedical information?, in Rothstein M (ed.): Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, CT, Yale University Press, 1997, pp. 60-73.
58.
58. Faden R: Reproductive genetic testing and the ethics of parenting. Fetal Diagn Ther8 (Suppl.1):142-147, 1993.
59.
59. Robertson JA: Procreative liberty and human genetics. Emory Law J39:697-719, 1990.
60.
60. Asch A: Public health matters: Prenatal diagnosis and selective abortion: A challenge to practice and policy. Am J Public Health89(11):1649-1657, 1999.
61.
61. Parens E, Asch A: The disability rights critique of prenatal genetic testing: Reflections and recommendations. Hastings Cent Rep29(5):S1-22, 1999.
62.
62. Post SG: Selective abortion and gene therapy: Reflections on human limits. Hum Gene Ther2(3):229-233, 1991.
64. Collins F: Shattuck Lecture—Medical and societal consequences of the Human Genome Project. N Engl J Med341(1):28-37, 1999.
65.
65. Khoury MJ: Genetic epidemiology and the future of disease prevention and public health. Epidemiol Rev19(1):175-180, 1997.
66.
66. Piper MA, Lindenmayer JM, Lengerich EJ, et al: The role of state public health agencies in genetics and disease prevention: Results of a national survey. Public Health Rep116(1):22-31, 2001.
67.
67. Hanson MJ: Religious voices in biotechnology: The case of gene patenting. Hastings Cent Rep27(6):Suppl. 1-19, 1997.
68.
68. Campbell CS: In whose image? Religion and the controversy of human cloning. Second Opinion1:24-43, 1999.
69.
69. SilverLM: Remaking Eden: Cloning and Beyond in a Brave New World. New York, Avon Books, 1997.
70.
70. Fleck L: Genetic Ethics: Relevant Moral Values/Moral Considerations (Fall Community Dialogues). Ann Arbor, MI, Genome Technology and Reproduction: Values and Public Policy Project, 1996.
71.
71. Beauchamp D: Introduction: Ethical theory and public health, in Beauchamp D, Steinbock B (eds.): New Ethics for the Public’s Health. New York, Oxford University Press, 1999, pp. 3-23.
72.
72. Lappe M: Ethics and public health, in Coughlin SS (ed.): Ethics in Epidemiology and Clinical Research: Annotated Readings. Newton, MA, Epidemiology Resources, 1995, pp. 181-193.
73.
73. Pellegrino ED: Autonomy and coercion in disease prevention and health promotion. Theor Med5(1):83-91, 1984.
74.
74. Weed DL, Coughlin SS: Ethics in cancer prevention and control, in Greenwald P, Kramer BS, Weed DL (eds.): Cancer Prevention and Control. New York, Marcel Dekker, 1995, pp. 497-507.
75.
75. Wertz DC: Ethical and legal implications of the new genetics: Issues for discussion. Soc Sci Med35(4):495-505, 1992.
76.
76. Burgess MM, Hayden MR: Patients’ rights to laboratory data: Trinucleotide repeat length in Huntington disease. Am J Med Genet62(1):6-9, 1996.
77.
77. Jennings B: Beyond distributive justice in health reform. Hastings Cent Rep26(6):14-15, 1996.
78.
78. Beauchamp DE: The Health of the Republic: Epidemics, Medicine, and Moralism as Challenges to Democracy. Philadelphia, Temple University Press, 1988.
79.
79. Bayertz K: What’s special about molecular genetic diagnostics?J Med Philos23(3):247-254, 1998.
80.
80. Lachmann PJ: Public health and bioethics. J Med Philos23(3): 297-302, 1998.
81.
81. Cole P: The moral bases for public health interventions. Epidemiology6(1):78-83, 1994.
82.
82. Wilfond BS, Thomson EJ: Models of public health genetic policy development, in Khoury MJ, Burke W, Thomson EJ (eds.): Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. New York, Oxford University Press, 2000, pp. 61-81.
83.
83. Fost N: Ethical implications of screening asymptomatic individuals, in Beauchamp D, Steinbock B (eds.): New Ethics for the Public’s Health. New York, Oxford University Press, 1999, pp. 344-352.
84.
84. Mastroianni AC, Kahn JP: The importance of expanding current training in the responsible conduct of research. Acad Med73(12):1249-1254, 1998.
85.
85. Dibbern DA, Wold E: Workshop-based learning: A model for teaching ethics. JAMA274(9):770-771, 1995.
86.
86. Gutmann A, Thompson D: Deliberating about bioethics. Hastings Cent Rep27(3):38-41, 1997.
87.
87. Garland MJ, Hasnain R: Community responsibility and the development of Oregon’s health care priorities. Business & Professional Ethics J9(3 & 4):183-200, 1990.
88.
88. Fleck L: Just Caring: Conflicting Rights /Uncertain Responsibilities. Lansing, MI, Just Caring Program, 1992.
89.
89. Young IM: Inclusion and Democracy. New York, Oxford University Press, 2000.
90.
90. Yankelovich D: The Magic of Dialogue. New York, Simon & Schuster, 1999.
91.
91. Bohman J: Public Deliberation: Pluralism, Complexity, and Democracy. Cambridge, MIT Press, 1996.
92.
92. Fishkin JS: Democracy and Deliberation: New Directions for Democratic Reform. New Haven, CT, Yale University Press, 1991.
93.
93. Coughlin SS: Model curricula in public health ethics. Am J Prev Med12(4):247-251, 1996.
94.
94. Morris MW, Sharp RR, Freeman WL, et al: The role of community review in evaluating the risks of human genetic variation research. Am J Hum Genet64(6):1719-1727, 1999.
95.
95. Israel B, Schulz AJ, Parker EA, Becker AB: Review of community-based research: Assessing partnership approaches to improve public health. Annu Rev Public Health19:173-202, 1998.
96.
96. Austin M, Peyser P: The multidisciplinary nature of public health genetics in research and education, in Khoury MJ, Burke W, Thomson EJ (eds.): Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. New York, Oxford University Press, 2000, pp. 83-100.
